APA (7th ed.) Citation

Bochtler, T., Hegenbart, U., Kimmich, C., Seckinger, A., Hose, D., Goldschmidt, H., . . . Schönland, S. (2016). Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: A long-term follow-up study. Blood, 128(4), . https://doi.org/10.1182/blood-2015-10-676361

Chicago Style (17th ed.) Citation

Bochtler, Tilmann, et al. "Prognostic Impact of Cytogenetic Aberrations in AL Amyloidosis Patients After High-dose Melphalan: A Long-term Follow-up Study." Blood 128, no. 4 (2016). https://doi.org/10.1182/blood-2015-10-676361.

MLA (9th ed.) Citation

Bochtler, Tilmann, et al. "Prognostic Impact of Cytogenetic Aberrations in AL Amyloidosis Patients After High-dose Melphalan: A Long-term Follow-up Study." Blood, vol. 128, no. 4, 2016, https://doi.org/10.1182/blood-2015-10-676361.